Abstract
Monocyte–platelet aggregates (MPA) are increased in patients with acute coronary syndrome. We investigated whether MPA are associated with the presence of functionally significant coronary stenoses or with coronary arterial endothelial dysfunction. One hundred forty five patients undergoing elective coronary angiography were prospectively enrolled. Functional significance of coronary stenosis was assessed by fractional flow reserve (FFR). Thirty randomly selected patients underwent pacing protocol to evaluate Coronary endothelium-dependent vasomotor function (CVF). Whole blood was drawn to evaluate MPA. In patients with FFR ≤ 0.8 (FFRpos, n = 75), MPA did not significantly differ from FFR >0.8 patients (FFRneg, n = 70) (38.1 % [25.7–56.6] vs 34.0 % [20.5–49.9], p = 0.08). CVF was similar in FFRpos and FFRneg patients (percent vessel diameter change, %VDC = 7.19 % [6.01–10.9] vs 8.0 % [0.81–9.80], p = 0.78). Yet, patients with abnormal CVF showed higher MPA as compared to patients with preserved CVF (28.3 % [28.8–53.4] vs 20.5 % [17.0–32.9], p = 0.01). Moreover, MPA was inversely correlated with %VDC (R 2 = 0.26, p < 0.01). MPA levels are significantly higher in patients with abnormal coronary vasomotor function regardless of the presence of functionally significant coronary stenosis.
Similar content being viewed by others
References
Ruggeri, Z. M. (2002). Platelets in atherothrombosis. Nature Medicine, 8(11), 1227–1234. doi:10.1038/nm1102-1227.
Davi, G., & Patrono, C. (2007). Platelet activation and atherothrombosis. The New England Journal of Medicine, 357(24), 2482–2494. doi:10.1056/NEJMra071014.
Danenberg, H. D., Kantak, N., Grad, E., Swaminathan, R. V., Lotan, C., & Edelman, E. R. (2007). C-reactive protein promotes monocyte–platelet aggregation: an additional link to the inflammatory-thrombotic intricacy. European Journal of Haematology, 78(3), 246–252. doi:10.1111/j.1600-0609.2006.00808.x.
Kalsch, T., Elmas, E., Nguyen, X. D., Suvajac, N., Kluter, H., Borggrefe, M., & Dempfle, C. E. (2007). Endotoxin-induced effects on platelets and monocytes in an in vivo model of inflammation. Basic Research in Cardiology, 102(5), 460–466. doi:10.1007/s00395-007-0667-y.
Passacquale, G., Vamadevan, P., Pereira, L., Hamid, C., Corrigall, V., & Ferro, A. (2011). Monocyte–platelet interaction induces a pro-inflammatory phenotype in circulating monocytes. PloS one, 6(10), e25595. doi:10.1371/journal.pone.0025595.
Furman, M. I., Benoit, S. E., Barnard, M. R., Valeri, C. R., Borbone, M. L., Becker, R. C., Hechtman, H. B., & Michelson, A. D. (1998). Increased platelet reactivity and circulating monocyte–platelet aggregates in patients with stable coronary artery disease. Journal of the American College of Cardiology, 31(2), 352–358.
Hamilos, M., Sarma, J., Ostojic, M., Cuisset, T., Sarno, G., Melikian, N., Ntalianis, A., Muller, O., Barbato, E., Beleslin, B., Sagic, D., De Bruyne, B., Bartunek, J., & Wijns, W. (2008). Interference of drug-eluting stents with endothelium-dependent coronary vasomotion: evidence for device-specific responses. Circulation. Cardiovascular Interventions, 1(3), 193–200. doi:10.1161/CIRCINTERVENTIONS.108.797928.
Gordon, J. B., Ganz, P., Nabel, E. G., Fish, R. D., Zebede, J., Mudge, G. H., Alexander, R. W., & Selwyn, A. P. (1989). Atherosclerosis influences the vasomotor response of epicardial coronary arteries to exercise. The Journal of Clinical Investigation, 83(6), 1946–1952. doi:10.1172/JCI114103.
Robinson, S. D., Harding, S. A., Cummins, P., Din, J. N., Sarma, J., Davidson, I., Fox, K. A., Boon, N. A., & Newby, D. E. (2006). Functional interplay between platelet activation and endothelial dysfunction in patients with coronary heart disease. Platelets, 17(3), 158–162. doi:10.1080/17476930500454514.
Chatzizisis, Y. S., Coskun, A. U., Jonas, M., Edelman, E. R., Feldman, C. L., & Stone, P. H. (2007). Role of endothelial shear stress in the natural history of coronary atherosclerosis and vascular remodeling: molecular, cellular, and vascular behavior. Journal of the American College of Cardiology, 49(25), 2379–2393. doi:10.1016/j.jacc.2007.02.059.
Mangiacapra, F., & Barbato, E. (2013). Clinical implications of platelet–vessel interaction. Journal of Cardiovascular Translational Research, 6(3), 310–315. doi:10.1007/s12265-012-9441-0.
Muller, O., Bartunek, J., Hamilos, M., Berza, C. T., Mangiacapra, F., Ntalianis, A., Vercruysse, K., Duby, C., Wijns, W., De Bruyne, B., Heyndrickx, G. R., Vanderheyden, M., Holz, J. B., & Barbato, E. (2013). von Willebrand factor inhibition improves endothelial function in patients with stable angina. Journal of Cardiovascular Translational Research, 6(3), 364–370. doi:10.1007/s12265-012-9422-3.
Mayadas, T. N., Johnson, R. C., Rayburn, H., Hynes, R. O., & Wagner, D. D. (1993). Leukocyte rolling and extravasation are severely compromised in P selectin-deficient mice. Cell, 74(3), 541–554.
Massberg, S., Brand, K., Gruner, S., Page, S., Muller, E., Muller, I., Bergmeier, W., Richter, T., Lorenz, M., Konrad, I., Nieswandt, B., & Gawaz, M. (2002). A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. The Journal of Experimental Medicine, 196(7), 887–896.
Theilmeier, G., Michiels, C., Spaepen, E., Vreys, I., Collen, D., Vermylen, J., & Hoylaerts, M. F. (2002). Endothelial von Willebrand factor recruits platelets to atherosclerosis-prone sites in response to hypercholesterolemia. Blood, 99(12), 4486–4493.
Diodati, J. G., Dakak, N., Gilligan, D. M., & Quyyumi, A. A. (1998). Effect of atherosclerosis on endothelium-dependent inhibition of platelet activation in humans. Circulation, 98(1), 17–24.
Rosenblum, W. I. (1997). Platelet adhesion and aggregation without endothelial denudation or exposure of basal lamina and/or collagen. Journal of Vascular Research, 34(6), 409–417.
Bogaty, P., Brecker, S. J., White, S. E., Stevenson, R. N., El-Tamimi, H., Balcon, R., & Maseri, A. (1993). Comparison of coronary angiographic findings in acute and chronic first presentation of ischemic heart disease. Circulation, 87(6), 1938–1946.
Pijls, N. H., De Bruyne, B., Peels, K., Van Der Voort, P. H., Bonnier, H. J., Bartunek, J. K. J. J., & Koolen, J. J. (1996). Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. The New England Journal of Medicine, 334(26), 1703–1708. doi:10.1056/NEJM199606273342604.
De Bruyne, B., Pijls, N. H., Bartunek, J., Kulecki, K., Bech, J. W., De Winter, H., Van Crombrugge, P., Heyndrickx, G. R., & Wijns, W. (2001). Fractional flow reserve in patients with prior myocardial infarction. Circulation, 104(2), 157–162.
De Bruyne, B., Pijls, N. H., Barbato, E., Bartunek, J., Bech, J. W., Wijns, W., & Heyndrickx, G. R. (2003). Intracoronary and intravenous adenosine 5′-triphosphate, adenosine, papaverine, and contrast medium to assess fractional flow reserve in humans. Circulation, 107(14), 1877–1883. doi:10.1161/01.CIR.0000061950.24940.88.
Galassi, A. R., Tomasello, S. D., Crea, F., Costanzo, L., Campisano, M. B., Marza, F., & Tamburino, C. (2012). Transient impairment of vasomotion function after successful chronic total occlusion recanalization. Journal of the American College of Cardiology, 59(8), 711–718. doi:10.1016/j.jacc.2011.10.894.
Hamilos, M. I., Ostojic, M., Beleslin, B., Sagic, D., Mangovski, L., Stojkovic, S., Nedeljkovic, M., Orlic, D., Milosavljevic, B., Topic, D., Karanovic, N., & Wijns, W. (2008). Differential effects of drug-eluting stents on local endothelium-dependent coronary vasomotion. Journal of the American College of Cardiology, 51(22), 2123–2129. doi:10.1016/j.jacc.2007.12.059.
Harding, S. A., Din, J. N., Sarma, J., Jessop, A., Weatherall, M., Fox, K. A., & Newby, D. E. (2007). Flow cytometric analysis of circulating platelet–monocyte aggregates in whole blood: methodological considerations. Thrombosis and Haemostasis, 98(2), 451–456.
Lusis, A. J. (2000). Atherosclerosis. Nature, 407(6801), 233–241. doi:10.1038/35025203.
Egan, K. M., Wang, M., Fries, S., Lucitt, M. B., Zukas, A. M., Pure, E., Lawson, J. A., & FitzGerald, G. A. (2005). Cyclooxygenases, thromboxane, and atherosclerosis: plaque destabilization by cyclooxygenase-2 inhibition combined with thromboxane receptor antagonism. Circulation, 111(3), 334–342. doi:10.1161/01.CIR.0000153386.95356.78.
Pratico, D., Cyrus, T., Li, H., & FitzGerald, G. A. (2000). Endogenous biosynthesis of thromboxane and prostacyclin in 2 distinct murine models of atherosclerosis. Blood, 96(12), 3823–3826.
Dong, Z. M., Chapman, S. M., Brown, A. A., Frenette, P. S., Hynes, R. O., & Wagner, D. D. (1998). The combined role of P- and E-selectins in atherosclerosis. The Journal of Clinical Investigation, 102(1), 145–152. doi:10.1172/JCI3001.
Dong, Z. M., Brown, A. A., & Wagner, D. D. (2000). Prominent role of P-selectin in the development of advanced atherosclerosis in ApoE-deficient mice. Circulation, 101(19), 2290–2295.
Burger, P. C., & Wagner, D. D. (2003). Platelet P-selectin facilitates atherosclerotic lesion development. Blood, 101(7), 2661–2666. doi:10.1182/blood-2002-07-2209.
Lindemann, S., Tolley, N. D., Dixon, D. A., McIntyre, T. M., Prescott, S. M., Zimmerman, G. A., & Weyrich, A. S. (2001). Activated platelets mediate inflammatory signaling by regulated interleukin 1beta synthesis. The Journal of Cell Biology, 154(3), 485–490. doi:10.1083/jcb.200105058.
McEver, R. P. (2001). Adhesive interactions of leukocytes, platelets, and the vessel wall during hemostasis and inflammation. Thrombosis and Haemostasis, 86(3), 746–756.
Henn, V., Slupsky, J. R., Grafe, M., Anagnostopoulos, I., Forster, R., Muller-Berghaus, G., & Kroczek, R. A. (1998). CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature, 391(6667), 591–594. doi:10.1038/35393.
Subramaniam, M., Saffaripour, S., Watson, S. R., Mayadas, T. N., Hynes, R. O., & Wagner, D. D. (1995). Reduced recruitment of inflammatory cells in a contact hypersensitivity response in P-selectin-deficient mice. The Journal of Experimental Medicine, 181(6), 2277–2282.
Sarma, J., Laan, C. A., Alam, S., Jha, A., Fox, K. A., & Dransfield, I. (2002). Increased platelet binding to circulating monocytes in acute coronary syndromes. Circulation, 105(18), 2166–2171.
De Bruyne, B., Pijls, N. H., Kalesan, B., Barbato, E., Tonino, P. A., Piroth, Z., Jagic, N., Mobius-Winkler, S., Rioufol, G., Witt, N., Kala, P., MacCarthy, P., Engstrom, T., Oldroyd, K. G., Mavromatis, K., Manoharan, G., Verlee, P., Frobert, O., Curzen, N., Johnson, J. B., Juni, P., & Fearon, W. F. (2012). Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. The New England Journal of Medicine, 367(11), 991–1001. doi:10.1056/NEJMoa1205361.
Gremmel, T., Kopp, C. W., Seidinger, D., Giurgea, G. A., Koppensteiner, R., Steiner, S., & Panzer, S. (2009). The formation of monocyte-platelet aggregates is independent of on-treatment residual agonists'-inducible platelet reactivity. Atherosclerosis, 207(2), 608–613. doi:10.1016/j.atherosclerosis.2009.05.037.
Acknowledgments
This work has been supported by the Meijer Lavino Foundation for Cardiac Research, Aalst, Belgium.
Disclosures
None
Author information
Authors and Affiliations
Corresponding author
Additional information
Associate Editor Dominick Angiolillo
Luigi Di Serafino and Jaydeep Sarma contributed equally to this work.
Rights and permissions
About this article
Cite this article
Di Serafino, L., Sarma, J., Dierickx, K. et al. Monocyte–Platelets Aggregates as Cellular Biomarker of Endothelium-Dependent Coronary Vasomotor Dysfunction in Patients with Coronary Artery Disease. J. of Cardiovasc. Trans. Res. 7, 1–8 (2014). https://doi.org/10.1007/s12265-013-9520-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12265-013-9520-x